USFDA, Indian Government Join hands to clamp down on Illicit Medical Products Medical Dialogues Bureau19 Feb 2020 12:54 PM ISTUS: The U.S. Food and Drug Administration today announced that its first bilateral enforcement operation with the Government of India stopped...
Minister inaugurates Syngene new RnD centre in Hyderabad Medical Dialogues Bureau18 Feb 2020 4:19 PM ISTThis is Syngene International Ltd.'s first operational research centre outside Bengaluru. When fully commissioned by the end of this year at an...
Govt approved Rs 1750 crore proposal for strengthening drug regulatory system Medical Dialogues Bureau18 Feb 2020 2:56 PM ISTOut of this, Rs 900 crore is for strengthening the central drug regulator structure and Rs 850 crore is for strengthening the drug regulatory system...
Prices of Paracetamol surge by 40pc as coronavirus shuts China Farhat Nasim18 Feb 2020 1:21 PM ISTPrices of paracetamol, the most commonly used analgesic, have jumped by 40% in India, while the cost of azithromycin, an antibiotic used for treating...
Marketing right for SGLT2 inhibitor Apleway to be transferred from Sanofi to Kowa Medical Dialogues Bureau18 Feb 2020 12:53 PM ISTChugai and Sanofi agreed to terminate their license agreement. Kowa and Sanofi agreed that the marketing right for Apleway will be transferred from...
AstraZeneca 2020 revenue rises, sales growth to take coronavirus hit Medical Dialogues Bureau18 Feb 2020 10:30 AM ISTAstraZeneca said the guidance assumed an unfavourable impact from China lasting up to a few months as a result of the outbreak, which has killed over...
Merck Keytruda, Chemotherapy combo meets endpoint for first-line treatment of Breast Cancer Medical Dialogues Bureau18 Feb 2020 10:15 AM ISTNew Delhi: Merck known as MSD outside the United States and Canada, recently announced that the pivotal Phase 3 KEYNOTE-355 trial investigating...
USFDA completes inspection of Lupin's Aurangabad facility Medical Dialogues Bureau17 Feb 2020 4:18 PM ISTMumbai: Pharma major Lupin Limited (Lupin) announced the completion of the United States Food and Drug Administration (U.S. FDA) inspection carried...
Antios Therapeutics Initiates First-in-Human Phase I Study of ATI-2173 Medical Dialogues Bureau17 Feb 2020 3:51 PM ISTAtlanta: Antios Therapeutics, Inc a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure...
USFDA seeks voluntary action at Dr Reddy's Duvvada facility Medical Dialogues Bureau17 Feb 2020 3:10 PM ISTNew Delhi: The US health regulator has asked drug major Dr Reddy's Laboratories to initiate voluntary action at its Duvvada facility in Andhra...
Unichem, Macleods Pharma recall drugs from US market Medical Dialogues Bureau17 Feb 2020 3:09 PM ISTThe reason for the voluntary ongoing nationwide is "failed impurities/degredation specifications.
Zydus Cadila announces research Program to develop Coronavirus Vaccine Medical Dialogues Bureau17 Feb 2020 2:56 PM ISTZydus has two state-of-the-art R&D Centres, one located in Catania, Italy and the other in Ahmedabad, in the western part of India
